Chi-Chi Peng

Bristol-Myers Squibb (Germany) — Germany

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

4h-index127citations4works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(4), Computational Drug Discovery Methods(2), Drug Transport and Resistance Mechanisms(2), Antifungal resistance and susceptibility(1), Health Systems, Economic Evaluations, Quality of Life(1)

Publications4 total

Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
Drug Metabolism and Disposition·2013· 36 citedOpen Access
Stereospecific Metabolism of Itraconazole by CYP3A4: Dioxolane Ring Scission of Azole Antifungals
Drug Metabolism and Disposition·2011· 30 citedOpen Access
The kinetic mechanism for cytochrome P450 metabolism of Type II binding compounds: Evidence supporting direct reduction
Archives of Biochemistry and Biophysics·2011· 31 citedOpen Access
A model validation and consensus building environment
SAR and QSAR in environmental research·2006· 30 cited

Frequent Co-authors

Nina Isoherranen(2), Yoshiyuki Shirasaka(1), Shu Ying Chang(1), Mary F. Grubb(1), Kenneth E. Thummel(1), A. David Rodrigues(1), Joshua T. Pearson(1), Upendra P. Dahal(1), Daniel Röck(1), James O. Schenk(1), Carolyn A. Joswig-Jones(1), Jeffrey P. Jones(1), Wei Shi(1), Justin D. Lutz(1), Kent L. Kunze(1), Jun O. Liu(1), Wendel L. Nelson(1), T. Abshear(1), Gregory M. Banik(1), Marcus D’Souza(1)